ArticleDiscover oncology2026

Comparing immunotherapy re-challenge plus chemoradiotherapy versus chemoradiotherapy alone in metastatic esophageal squamous cell carcinoma after first-line immunotherapy failure.

Jian Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.